Open AccessContrast-enhanced18F-fluorodeoxyglucose positron emission tomography/computed tomography in immunoglobulin G4-related retroperitoneal fibrosis
Author(s) -
Punit Sharma,
Piyali Chatterjee
Publication year - 2015
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/0972-3919.147551
Subject(s) - medicine , retroperitoneal fibrosis , computed tomography , positron emission tomography , radiology , nuclear medicine , fluorodeoxyglucose , positron emission tomography computed tomography , fibrosis , igg4 related disease , tomography , pathology
Immunoglobulin G4 (IgG4)-related disease encompasses a wide variety of immune disorders previously thought be distinct. IgG4-related retroperitoneal fibrosis is one such entity. Metabolic imaging with (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) can be useful in the management of IgG4-related retroperitoneal fibrosis. We here discuss the case of 63-year-old male with IgG4-related retroperitoneal fibrosis and the role, (18)F-FDG PET/CT played in his management.